Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitral Regurgitation.

Asher1, Stewart

  • 1Cleveland Clinic, Desk F-15, Department of Cardiology, 9500 Euclid Avenue, Cleveland, OH 44195-0001, USA. stewarw@cesmtp.ccf.org

Current Treatment Options in Cardiovascular Medicine
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dermatophytosis in show lambs in the United States.

Veterinary dermatology·2021
Same author

A Case of Cerebro-Spinal Meningitis. Recovery.

Edinburgh medical journal·2018
Same author

Notes on Sanitation.

The Indian medical gazette·2017
Same author

Some Observations on the Use of Opium in Uterine Hemorrhagy.

Medico-chirurgical transactions·2010
Same author

Jumping champions

Scientific American·2000
Same author

Model for cw laser collisionally induced fluorescence in low-temperature discharges

Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics·2000
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Optimal timing for surgery in chronic severe mitral regurgitation is crucial. Surgery is recommended for symptomatic patients or those with signs of heart decompensation, not typically for asymptomatic individuals.

Area of Science:

  • Cardiology
  • Cardiac Surgery

Background:

  • Chronic severe mitral regurgitation is a surgically correctable condition.
  • Advancements in cardiac surgery have lowered surgical risks and improved outcomes.
  • Determining the ideal timing for surgical intervention remains a key challenge.

Purpose of the Study:

  • To review the current understanding of optimal surgical timing for chronic severe mitral regurgitation.
  • To highlight the importance of clinical and diagnostic data in surgical decision-making.

Main Methods:

  • Review of clinical guidelines and relevant literature.
  • Analysis of factors influencing surgical timing decisions.
  • Consideration of diagnostic imaging in assessing myocardial decompensation.

Related Experiment Videos

Main Results:

  • Surgery is indicated for symptomatic patients or those with evidence of myocardial decompensation.
  • Asymptomatic patients without progressive disease generally do not require immediate surgery.
  • Medical therapy is not proven to delay the need for surgery effectively.

Conclusions:

  • Surgical timing should be individualized based on clinical status, patient preference, and surgical expertise.
  • Early detection of occult myocardial decompensation is vital for timely surgical referral.
  • While some vasodilators show hemodynamic benefits, large trials do not support delaying surgery with medical therapy.